Evidence map›Paper›PMID 30339988›Full record

ReviewCurrent opinion in neurobiology2018

Assembly and repair of eye-to-brain connections.

Supraja G Varadarajan, Andrew D Huberman

Abstract readReview
In one paragraph

Review in Current opinion in neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Supraja G VaradarajanDepartment of Neurobiology, Stanford University School of Medicine, Stanford, United States.
Andrew D HubermanDepartment of Neurobiology, Stanford University School of Medicine, Stanford, United States; Department of Ophthalmology, Stanford University School of Medicine, Stanford, United States; BioX, Stanford University School of Medicine, Stanford, United States; Neurosciences Institute, Stanford University School of Medicine, Stanford, United States. Electronic address: adh1@stanford.edu.

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Molecular Discovery for Optic Nerve RegenerationU01EY027261 · NEI · STANFORD UNIVERSITY · PI GOLDBERG, JEFFREY L, HUBERMAN, ANDREW D · 2016 to 2019
$3.0M
Molecular and functional regeneration of the accessory optic pathwayR01EY027713 · NEI · JOHNS HOPKINS UNIVERSITY · PI HUBERMAN, ANDREW D, KOLODKIN, ALEX L · 2017 to 2020
$2.4M
Promoting optic nerve and retinofugal pathway regenerationR01EY026100 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HUBERMAN, ANDREW D · 2016 to 2019
$1.6M
NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY026100NEI NIH HHS R01 EY027713NEI NIH HHS U01 EY027261
6 · The paper itself

Abstract

Vision is the sense humans rely on most to navigate the world and survive. A tremendous amount of research has focused on understanding the neural circuits for vision and the developmental mechanisms that establish them. The eye-to-brain, or 'retinofugal' pathway remains a particularly important model in these contexts because it is essential for sight, its overt anatomical features relate to distinct functional attributes and those features develop in a tractable sequence. Much progress has been made in understanding the growth of retinal axons out of the eye, their selection of targets in the brain, the development of laminar and cell type-specific connectivity within those targets, and also dendritic connectivity within the retina itself. Moreover, because the retinofugal pathway is prone to degeneration in many common blinding diseases, understanding the cellular and molecular mechanisms that establish connectivity early in life stands to provide valuable insights into approaches that re-wire this pathway after damage or loss. Here we review recent progress in understanding the development of retinofugal pathways and how this information is important for improving visual circuit regeneration.

Indexed as

AnimalsAxonsHumansNerve RegenerationOptic NerveOptic TractRetinal Ganglion CellsVisual Pathways

Identifiers

PMID30339988
PMCPMC6504177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.